Study on Gastric or Gastroesophageal Cancer Treatment
This study is looking at a medication called paclitaxel for people with gastric (stomach) or gastroesophageal cancer. The goal is to find the best dose of this medication and understand its side effects. Paclitaxel is a type of chemotherapy which helps stop cancer cells from growing and spreading.
Key Points:
- Length of Study: Patients receive treatment weekly for 6 weeks, followed by check-ups every 6 months for 5 years.
- Who Can Join: Adults with gastric or gastroesophageal cancer, specific blood counts, and no serious infections or heart issues.
- Time Commitment: Weekly visits for treatment during specified weeks, with long-term follow-up required.
Eligibility: You must have proof of certain types of cancer and completed prior chemotherapy. Women must not be pregnant, and all participants must use birth control. You cannot join if you have certain heart issues, infections, or allergies to chemotherapy.
If you think this study could be right for you or someone you care for, please consider discussing it with a healthcare provider.
How understandable was the trial content above?
Hard to understand
Easy to understand